Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

16. Juin 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3022


	Articles 1 - 20 / 60438

	Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials. Diabetes Obes Metab Chiang CH, Bahar F, Chang YC, Wang TH, Hsia YP, Chiang CH. PMID: 42297743 [PubMed - as supplied by publisher]
	Risk of pancreatic cancer associated with precursor lesions in individuals and first-degree relatives: a nationwide cohort study. Clin Gastroenterol Hepatol Ludvigsson JF, Sun J, Yuan C, Vujasinovic M, Löhr JM, Wolpin BM, Wang QL. PMID: 42297317 [PubMed - as supplied by publisher]
	Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma. JTO Clin Res Rep Kok PS, Chan B, Aberoumoud M, Zhang A, O'Byrne K, Thavaneswaran S, Lin F, Kansara M, Corpuz T, Wheeler P, Simes RJ, Thomas D, Lee CK. PMID: 42293288 [PubMed]
	LncRNA MIR22HG and miR-10a-5p: Pioneering serum biomarkers for pancreatic cancer diagnosis and progression assessment. Noncoding RNA Res Salman RM, Radwan AF, Shaker OG, El-Husseiny AA. PMID: 42293029 [PubMed]
	Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma. Front Immunol Wang Z, Tang J, Zhu S, Li S, Yao B, Tu J, Zhou X, Tang Q, Zhong L. PMID: 42292467 [PubMed - indexed for MEDLINE]
	The life cycle of tertiary lymphoid structures in pancreatic cancer-a window of opportunity for immunotherapy. Front Immunol Chen Y, Xiao Y, Zhang T, Wang X. PMID: 42292349 [PubMed - indexed for MEDLINE]
	Nimotuzumab combined with gemcitabine and nab-paclitaxel as first-line therapy for advanced pancreatic cancer: a single-arm, single-center Phase II prospective study. Front Med (Lausanne) Lin L, Zhao X, Luo Y, Cai JH, Lin Z, Xiao L, Tian G, He S. PMID: 42292240 [PubMed]
	Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy. iScience Pan Z, Zhang F, Zhang C, Li X, Ma Y, Yang Y, Tian X. PMID: 42291273 [PubMed]
	Natural Products and Long Noncoding RNAs: A Complex Regulatory Network in Pancreatic Cancer Progression and Treatment. J Biochem Mol Toxicol Elimam H, Radwan AF, Elfar N, Ghaiad HR, Abd-Elmawla MA, Zaki MB, Nassar K, Mohammed OA, Doghish AS. PMID: 42290329 [PubMed - indexed for MEDLINE]
	Central Pancreatectomy with Duct-to-Mucosa Pancreaticogastrostomy Using a Knotless Continuous Suturing Technique: Initial Experience with a Totally Laparoscopic Approach. Asian J Endosc Surg Kawashima M, Matsushita A, Hamaguchi A, Kato Y, Ono T, Irie T, Ga R, Aoki Y, Oshiro Y, Nakamura Y. PMID: 42289762 [PubMed - indexed for MEDLINE]
	Study on the inhibition of liver cancer progression by lenvatinib nanoparticles combined with hyaluronic acid/gelatin scaffold. Colloids Surf B Biointerfaces Zhu L, Chen H, Guo Q, Ren C, Shi P, Wang Q, Hu Y, Fan Z, Xu Y, Lin D, Chen H. PMID: 42287829 [PubMed - as supplied by publisher]
	6-mm versus 10-mm covered self-expandable metal stents and plastic stents for malignant distal biliary obstruction in resectable or borderline resectable pancreatic cancer in Japan (STARDOM, JON-2402P): study protocol for a multicenter randomized controlled trial. Trials Yamashige D, Hijioka S, Yasuda I, Hayashi N, Taguri M, Ueno M, Furuse J, Japan Oncology Network in Hepatobiliary and Pancreas. PMID: 42286634 [PubMed - as supplied by publisher]
	Intraductal Papillary Mucinous Neoplasm Worsening Glycemic Control in a Patient with Type 2 Diabetes Mellitus. Am J Med Sci Varghese RT, Ayar UD, Zamin MR, Oyalade FK, Valencia VC, Aoun ML. PMID: 42285223 [PubMed - as supplied by publisher]
	Health-related quality of life among patients with colorectal und pancreatic cancer: results from a monocentric registry study. Gesundheitswesen Piontek D, Schoffer O, Datzmann T, Boehme H, Distler M, Fritzmann J, Hempel S, Oehme F, Radulova-Mauersberger O, Ubbelohde U, Bornhaeuser M, Weitz J, Schmitt J. PMID: 42285169 [PubMed - as supplied by publisher]
	Clinicopathological features of pancreatic solid pseudopapillary neoplasm: A retrospective single-center study of 32 cases in Guangzhou, China. Pathol Res Pract Quan S, Li G, Liu S, Wu J, He P, Hu J. PMID: 42284974 [PubMed - as supplied by publisher]
	Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Cell Rep Shrivastava A, Pederson EN, Nguyen TU, Chuen J, Mohan P, Pande S, Toribio AR, Lecomte N, Melchor J, McAuliffe JC, Grandgenett PM, Rajasekhar VK, Nishikawa K, Knörlein A, David Y, Willis IM, Iacobuzio-Donahue CA, Ouyang Z, Singh K. PMID: 42284146 [PubMed - as supplied by publisher]
	CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation. Hum Mutat Jiang Z, Ma P, Zhang S, Jin Z, Wang Y, Zhou Y, Zhu Q, Lu C, Tu N, Zhang ZA, Mou Y, Jin W. PMID: 42282992 [PubMed - indexed for MEDLINE]
	Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis. J Natl Cancer Cent Yu J, Zhou Q, Wang G, Shi S, Wang H, Yang J, Sun X, Li J, Shi Y, Wang J, Guo X, Zou Y, Xie Y, Zhang Z, Zhang Y, Cai S, Hao J. PMID: 42282129 [PubMed]
	From Standard of Care to mRNA Cancer Vaccines and Spatial Architecture-Based Precision Therapy in PDAC: Challenges and Expectations. Cancers (Basel) Stea EX, Kydonakis N, Roukos DH. PMID: 42279406 [PubMed]
	Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations. Cancers (Basel) Imaoka H, Ikeda M, Wakabayashi M, Umemoto K, Satake T, Sunakawa Y, Ueno H, Hara K, Nagashima F, Kataoka S, Hisano T, Suzuki Y, Asagi A, Shioji K, Oshima K, Tsuji K, Ohkawa K, Miki I, Kawamoto Y, Yamashita T, Ueno M, Kawakami Y, Nagano H, Okuyama H, Naganuma A, Suzuki R, Furuse J, Japan Oncology Network in Hepatobiliary and Pancreas. PMID: 42279400 [PubMed]

Articles 1 - 20 / 60438

Page 1 de 3022



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité